E. IDAKA, Ph.D. S. MOTOJIMA, Ph.D.
Eiichi IDAKA, Ph.D., Natural Chemist, CEO of epharm Corporation, Pres. of The Society of Beautiful Health & Environment, Prof. Gifu Univ.
Seiji MOTOJIMA, Ph.D., Inorganic Chemist, CEO of CMC Research Institute Co. Ltd., Pres. of Japan Helical Science Society, Prof. Gifu Univ.
Shinzi KATO, Ph.D., Organic Chemist, Prof. Gifu Univ., Prof. Chubu Univ.
Date: 14:00-17:00, 19th. Mar. 2019.
Place: Department of Development of Thai Traditional Medicine and Alternative Medicine
Ministry of Public Health, Tiwanon Road, Talad Khwan, Muang District, Nonthabuli, 10110, Thailand. TEL +66-2149-5647
Prof. Narong Nimsakul
Organizer:
Prof. Narong Nimsakul, M.D.,F.I.C.S. Pres. Anti-Aging Society (Thailand).
Honorary Pres. Internl Soc. for Laser Surgery & Medicine.
Pres. Thailand-Japan Friendship Forum.
(https://thai-medical.info/narong/ http://www.pimtara.com)
Dr. Khwanchai Visithanon, M.D.
Dr. Khwanchai Visithanon, M.D. Director, Institute of Thai Traditional Medicine
DTAM, Ministry of Public Health, Thailand.
1. Structured Micronutrients 構造化微量要素 US PAT 1995
2. Helical Carbon (Carbon Micro Coil) PAT PCT 1990
3. Loquat Extract 枇杷構造水 US PAT
4. Uranium Radiation (10 Kg)
5. Osteopathic Therapy 十字式整体
6. Far-Infrared Irradiation JPN PAT
7. Hydrogen Absorption
8. SM, HC, LX Treatment at home for Cancer
9. Seven-Simultaneous Treatment at Saitama for Cancer
We have been engaged in manufacturing and development (PAT) of structured micronutrients obtained from deep sea water and new carbon material (helical carbon). It also has the only facility in Japan that possesses natural uranium for research on a large scale (Institute of Nuclear Science certificated by NRA/Pres. E. Idaka). Self-developed items 1-7 above are effective and active in cancer, atopic dermatitis, depression, AIDS, ulcerative colitis, MRSA destruction, etc. (PAT). The mechanism of action 1 to 7 will be discussed. In addition, in Section 8, clinical trial cases are given regarding alternative medicine at the stage IV of cancer using structured micronutrients (SM), helical carbon (HC), and Loquat Extract (LX). Furthermore, Section 9 introduces clinical trials in which patients with difficult terminal cancer were treated simultaneously for Sections 1-7.
